Table 1:

Collapsed classifier groups and pathologic response outcomes, pooled treatment arms

Classifier	# patients	Complete response, pT0N0 n (%; 95% CI)	Downstaging* (<pT2N0) n (%; 95% CI)
Total	155	51 (33%; 26%, 41%)	81 (52%; 44%, 60%)
TCGA  Basal/Sq + Neuronal	55	21 (38%; 25%, 52%)	26 (47%; 34%, 61%)
Luminal	77	25 (33%; 22%, 44%)	43 (56%; 44%, 67%)
Luminal infiltrated	23	5 (22%; 7%, 44%)	12 (52%; 31%, 73%)
Consensus  Ba, Sq, NE	51	17 (33%; 21%, 48%)	24 (47%; 33%, 62%)
Luminal	80	27 (34%; 24%, 45%)	46 (58%; 46%, 68%)
Stroma-rich	24	7 (29%; 13%, 51%)	11 (46%; 26%, 67%)
MDA  Basal	49	14 (29%; 17%, 43%)	23 (47%; 33%, 62%)
Luminal	56	22 (39%; 27%, 53%)	36 (64%; 50%, 77%)
p53-like	50	15 (30%; 18%, 45%)	22 (44%; 30%, 59%)

^*Downstaging category includes complete responders

TCGA – The Cancer Genome Atlas, Ba – Basal, Sq – Squamous, NE – neuroendocrine, MDA – MD Anderson